Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Protein and Resistance Exercise to Stop Sarcopenic Obesity Now (PRESS ON)

25 agosto 2026 aggiornato da: Drew Sayer, University of Alabama at Birmingham

Effects of Dietary Protein Intake and Resistance Training on Retention of Fat Free Mass During Weight Loss in Adults Over 50 With Obesity

The purpose of this study is to examine the separate and combined effects of a high-protein (HP) diet and resistance training (RT) on body composition and potential biological moderators of body weight in women and men >50y. All participants will receive dietary physical activity guidance through our group-based weight loss program, State of Slim (SOS). The SOS program will be delivered via the Zoom videoconferencing platform. These participants will be randomized to receive either a counseling-based HP diet plan or RT plan. Body composition assessments at 8 wk will identify responders and non-responders; the latter will be re-randomized to "augment" (HP: add protein supplements; RT: supervise RT) or "combine" (HP with protein supplements + supervised RT).

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This is a sequential multiple assignment randomized trial (SMART) experimental design. Study testing took place at the University of Alabama at Birmingham (UAB) Wellness, Health, and Research Facility (WHARF) on the Lakeshore Foundation Campus in Birmingham, Alabama.

Overview of the State of Slim Weight Management Program All study participants will be enrolled in the SOS weight management program. SOS is a 16-week group-based behavioral weight loss program (up to 20 per group). The usual SOS diet plan is HP, low in fat and emphasizes non-starchy vegetable and whole-grain carbohydrates. The diet is plan is structured into 3 distinct phases with phase-specific food choices from which participants can chose to eat in defined portions rather than counting calories. Phase 1 is 2 weeks long, Phase 2 is 6 weeks, and Phase 3 is 8 weeks, and additional foods are added to the food choices as participants complete each phase. The SOS diet plan utilizes 5 'Diet Rules' through all 3 phases of the diet to encourage weight loss: (i) Eat 6 times per day; (ii) Have breakfast within 1 h of waking; (iii) Don't count calories, measure portions; (iv) Have the right carbohydrate and protein mix at every meal (1 carbohydrate and 1 protein at every meal, vegetables as only carbohydrate source at 3 meals); and (v) Eat a healthy fat twice a day. SOS also includes a strong exercise component with a prescription to exercise on 6 days per week and to progressively increase exercise duration from 10 min/d to 70 min/d. Participants in the commercial SOS program are encouraged to reach the goal of 420 weekly minutes of exercise through any combination of aerobic, strength, and alternative (e.g., yoga, Pilates, flexibility, balance) exercise training. Weekly group sessions cover topics related to weight management and behavior change such as building motivation, managing stress, practicing new habits, and finding social support.

Research Modifications to State of Slim For this study, participants were randomly assigned to the HP group follow the unmodified SOS diet plan in the published book whereas participants assigned to the RT group follow a modified version (described below) with 3 days per week of self-direct RT that will contribute ~135 minutes per week (45 min/session) to the 420 minutes per week exercise goal (RT group). The 1st and 2nd stage SMART interventions for each group are described below. All participants had access to the online SOS community during the entire study where they could interact/connect with other participants from their group and also have access to the coach who will be available to provide information and answer questions. The SOS community is a private Facebook group that is only open to participants in that specific SOS group.

First-Stage Interventions- High Protein Diet Counseling Participants in this group followed the usual SOS diet. The estimated macronutrient distribution is 40% protein (or ~1.8 g/kg body weight/d), 32% carbohydrate, and 28% fat. Prior to the start of the intervention, participants completed a virtual orientation session with a personal trainer via zoom who demonstrated a sequence of balance and flexibility exercises (single limb stance, heel-to-toe walk, standing side leg raise, standing back leg raise). Participants were instructed to engage in this sequence and any other balance and flexibility exercises (i.e., yoga, Pilates etc.) for approximately 45 minutes per day that contributed to the overall 420 minutes per week and to avoid any RT for the duration of the study.

First-Stage Interventions- Standard Protein Diet Counseling plus RT In order to control for the overall degree of dietary energy restriction, participants assigned to RT were prescribed a modified SOS diet that is lower in protein (20% of energy or ~0.9 g/kg body weight/d), proportionally higher in carbohydrate (53% of energy), and approximately equivalent in fat (26% of energy), but using the same overall food sources. Protein portions listed in the SOS Diet Rules were decreased to 2-3 ounces per meal and requiring non-vegetable carbohydrate foods at all 6 meals to achieve targeted differences in macronutrient composition between the diet plans. Prior to initiating the SOS program, participants assigned to RT were given resistance bands (either Premium Versa Tube, Power Systems, Knoxville TN, 37909, USA or Black Mountain Resistance Bands Set, Black Mountain Products, Inc. Spring Grove, IL 60081, USA) to use for the duration of the study. They also completed a virtual RT orientation session with a personal trainer via zoom to demonstrate proper technique for exercises and discuss the plan for RT progression (e.g., increase number of sets). They were instructed to engage in self-directed RT using the provided resistance bands and work up to three sets of 8-12 repetitions of eight exercises (squat, heel raise, overhead press, chest press, row, arm curl, triceps push-down, and abdominal flexion). Participants were instructed to begin with one set of each exercise and to add additional sets once s/he was able to achieve 12 repetitions of all exercises.

Second-Stage Interventions- Intensify: Protein Supplementation Participants re-randomized to the HP + RT combination or the protein supplementation arm received a shaker cup at no cost for weeks 8-16. The supplement provided was Optimum Nutrition Gold Standard Whey Protein Isolate, available in multiple flavors from which participants could choose. Each serving contained 24 g of protein and 110 kcal when mixed with water. Participants were instructed to consume two servings daily through week 16.

Second-Stage Interventions- Intensity: Supervised RT Supervised RT was led by a personal trainer in a group setting on two days per week for weeks 9-16. The participants were instructed to continue completing one day of RT on their own. Exercises for the supervised RT were the same as those prescribed for the 1st stage RT intervention.

Second-Stage Interventions- Combine: HP+RT Participants randomized to combine the HP+RT group were instructed to follow the unmodified HP SOS diet plan and were given protein supplements and supervised RT as described above for weeks 9-16.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

89

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Alabama
      • Birmingham, Alabama, Stati Uniti, 35294-3360
        • University of Alabama at Birmingham

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

50 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Male or Female
  • Age ≥50 years
  • Post-menopausal if Female
  • BMI of 30-50 kg/m2 for ambulatory participants (less than or equal to 350 lbs.)
  • BMI of 25-50 kg/m2 for wheelchair users (less than or equal to 350 lbs.)
  • Ambulatory with or without a walking device or use of a manual wheelchair for mobility.

Exclusion Criteria:

  • Untreated hyper or hypothyroidism.
  • Cancer (except basal cell).
  • Gastrointestinal disorders affecting food intake.
  • <3 months of stable use of medications that affect metabolism, body weight, energy expenditure or appetite.
  • Current eating disorder (e.g., binge eating disorder, anorexia, or bulimia).
  • Any medical condition for which following a HP diet and/or 70 minutes of exercise daily would be inadvisable.
  • Uses a powered wheelchair for mobility.
  • Has a pacemaker or any other life-sustaining medical implant.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione sequenziale
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: High Protein Diet Counseling, Add Protein Supplement for Non-Responders (Intensify)

Enrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements to augment their intervention plan.

16 week group-based weight loss program with counseling to consume a high protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 32%:40%:28%.

For non-responding participants initially assigned to receive high-protein dietary counseling, whey protein supplements will be provided to participants with instruction to consume the supplement twice daily.

For non-responding participants initially assigned to receive resistance exercise training, participants will receive 2 days per week of small-group supervised resistance exercise training.

Sperimentale: Resistance Training Counseling, Supervised Resistance Training for Non-Responders (Intensify)

Enrollment in State of Slim (SOS) weight loss program with resistance training counseling sessions. Participants identified as non-responders at the week 8 assessment will receive supervised resistance exercise training sessions to augment their intervention plan.

For non-responding participants initially assigned to receive high-protein dietary counseling, whey protein supplements will be provided to participants with instruction to consume the supplement twice daily.

For non-responding participants initially assigned to receive resistance exercise training, participants will receive 2 days per week of small-group supervised resistance exercise training.

16 week weight loss program with resistance training counseling. Participants receive counseling to follow a full-body and progressive resistance exercise training program using resistance bands that are provided by the study.

Sperimentale: High Protein Diet Counseling, Combine Protein and Resistance Training for Non-Responders

Enrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements and supervised resistance training sessions to augment their intervention plan.

16 week group-based weight loss program with counseling to consume a high protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 32%:40%:28%.

Non-responders from either initial randomized group assigned to this intervention receive the twice daily protein supplements and twice weekly small-group supervised resistance exercise training sessions.

Sperimentale: Resistance Training Counseling, Combine Protein and Resistance Training for Non-Responders

Enrollment in State of Slim (SOS) weight loss program with resistance training counseling sessions. Participants identified as non-responders at the week 8 assessment will receive protein supplements and supervised resistance training sessions to augment their intervention plan.

16 week weight loss program with resistance training counseling. Participants receive counseling to follow a full-body and progressive resistance exercise training program using resistance bands that are provided by the study.

Non-responders from either initial randomized group assigned to this intervention receive the twice daily protein supplements and twice weekly small-group supervised resistance exercise training sessions.

Sperimentale: High Protein Diet Counseling, Responder

Enrolled in the State of Slim (SOS) weight loss program with counseling to consume a high protein. Met the criteria as a responder at the week 8 assessment and did not receive any second stage augmentation strategy.

16 week group-based weight loss program with counseling to consume a high protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 32%:40%:28%.

Sperimentale: Resistance Training Counseling, Responder

Enrolled in the State of Slim (SOS) weight loss program with counseling to engage in a full-body resistance exercise training program. Met the criteria as a responder at the week 8 assessment and did not receive any second stage augmentation strategy.

16 week weight loss program with resistance training counseling. Participants receive counseling to follow a full-body and progressive resistance exercise training program using resistance bands that are provided by the study.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Recruitment Rates
Lasso di tempo: Screening through randomization, up to 6 months.

Rates of study recruitment will be tracked to determine clinical trial feasibility. Outcome measures are determined by the percentage of people who were originally assessed for eligibility by phone (n=469) and advanced to the next stage of recruitment.

Screening through randomization, up to 6 months.
Retention Rate (Percentage of Participants Completing Week 16 Assessment)
Lasso di tempo: Baseline through week 16.

Retention rate is defined as the percentage of randomized participants who completed the Week 16 assessment, calculated as (number completing the Week 16 assessment divided by number randomized at baseline) x 100. In this pre-specified study outcome, retention rates are summarized by Stage 1 intervention arm.

Baseline through week 16.
Class Attendance
Lasso di tempo: Baseline through week 16.

Average percent of scheduled group classes attended per participant from baseline to week 16, calculated as (number of sessions attended ÷ number of sessions offered) × 100.

Baseline through week 16.
Stage 1 Treatment Credibility
Lasso di tempo: Baseline

Perceived credibility of Stage 1 interventions to produce weight loss will be measured at baseline (before responder/non-responders are identified) with the Credibility/Expectancy Questionnaire. Credibility is assessed by answering 3 questions and using a 9-point Likert scale with values ranging from 1: Not at all logical/useful/confident to 9: Very logical/useful/confident. Scores are summed across items to create a total credibility score ranging from 3 to 27, with higher scores indicating greater perceived credibility.

Baseline
Stage 2 Treatment Credibility
Lasso di tempo: Week 8

Perceived credibility of Stage 2 interventions to produce weight loss will be measured at Week 8 with the Credibility/Expectancy Questionnaire. Credibility is assessed by answering 3 questions and using a 9-point Likert scale with values ranging from 1: Not at all logical/useful/confident to 9: Very logical/useful/confident. Scores are summed across items to create a total credibility score ranging from 3 to 27, with higher scores indicating greater perceived credibility.

Week 8
Stage 1 Intervention Preference
Lasso di tempo: Baseline

Participant preferences for Stage 1 interventions will be measured at baseline by answering a 5-point Likert question with '1' and '5' representing a strong preference for either intervention and '3' representing no intervention preference. Only participants who completed the survey were analyzed.

Baseline
Stage 2 Intervention Preference
Lasso di tempo: Week 8

Participant preferences for Stage 2 interventions ("Intensify" versus "Combine") will be measured at week 8 by answering a 5-point Likert question with '1' and '5' representing a strong preference for either intervention and '3' representing no intervention preference. Only non-responders were asked to complete the questionnaire at this stage.

Week 8

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Body Weight: Least Squares Mean Change From Baseline to Week 16 (Stage 1 Main Effect: HP vs RT; All Participants)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 (Week 16 - baseline) by Stage 1 intervention (HP vs RT). The Stage 1 main effect is estimated as a marginal (averaged) effect over Week 8 responder status at Week 8 and among non-responders, over Stage 2 intervention assignment.

Baseline to Week 16
Body Weight: Least Squares Mean Change From Baseline to Week 16 (Stage 2 Main Effect: Combine vs Intensify; Non-Responders)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 among non-responders, where change = (Week 16 - Baseline). The Stage 2 main effect compares Intensify vs Combine, averaged over Stage 1 assignment.

Baseline to Week 16
Body Weight: Least Squares Mean Change From Baseline to Week 16 (Embedded Adaptive Interventions)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 for each embedded adaptive intervention (EAI), where change = (Week 16 - Baseline).

Baseline to Week 16
Fat Mass: Least Squares Mean Change From Baseline to Week 16 (Stage 1 Main Effect: HP vs RT; All Participants)
Lasso di tempo: Baseline to week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 (Week 16 - baseline) by Stage 1 intervention (HP vs RT). The Stage 1 main effect is estimated as a marginal (averaged) effect over Week 8 responder status at Week 8 and among non-responders, over Stage 2 intervention assignment.

Baseline to week 16
Fat Mass: Least Squares Mean Change From Baseline to Week 16 (Stage 2 Main Effect: Combine vs Intensify; Non-Responders)
Lasso di tempo: Baseline to week 16

Model-based (least squares / marginal) mean change from baseline to Week 16 among non-responders, where change = (Week 16 - Baseline). The Stage 2 main effect compares Intensify vs Combine, averaged over Stage 1 assignment.

Baseline to week 16
Fat Mass: Least Squares Mean Net Change From Baseline to Week 16 (Embedded Adaptive Interventions)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 for each embedded adaptive intervention (EAI), where change = (Week 16 - Baseline).

Baseline to Week 16
Fat-Free Mass: Least Squares Mean Change in From Baseline to Week 16 (Stage 1 Main Effect: HP vs RT; All Participants)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 (Week 16 - baseline) by Stage 1 intervention (HP vs RT). The Stage 1 main effect is estimated as a marginal (averaged) effect over Week 8 responder status at Week 8 and among non-responders, over Stage 2 intervention assignment.

Baseline to Week 16
Fat-Free Mass: Least Squares Mean Change From Baseline to Week 16 (Stage 2 Main Effect: Combine vs Intensify; Non-Responders)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean change from baseline to Week 16 among non-responders, where change = (Week 16 - Baseline). The Stage 2 main effect compares Intensify vs Combine, averaged over Stage 1 assignment.

Baseline to Week 16
Fat-Free Mass: Least Squares Mean Change From Baseline to Week 16 (Embedded Adaptive Interventions)
Lasso di tempo: Baseline to Week 16

Model-based (least squares / marginal) mean net change from baseline to Week 16 for each embedded adaptive intervention (EAI), where change = (Week 16 - Baseline).

Baseline to Week 16

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Drew Sayer, PhD, University of Alabama at Birmingham

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

12 aprile 2021

Completamento primario (Effettivo)

31 maggio 2024

Completamento dello studio (Effettivo)

31 maggio 2024

Date di iscrizione allo studio

Primo inviato

5 luglio 2019

Primo inviato che soddisfa i criteri di controllo qualità

5 luglio 2019

Primo Inserito (Effettivo)

10 luglio 2019

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

25 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB-300003818
  • K01DK124244 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .